ARCHIVES

Gallo’s Lab Moved From DCT to DCE; NCI Planning To Drop “Cancer Treatment Reports” At End Of ‘86

This article is from The Cancer Letter archive.

Vol. 13 No. 06 | February 6, 1987

Download PDF Visit The Full Archive

Related Articles

DCT Board Gives Concept Approval to Recompetition Of In Vitro Assay For New Drug Screening Program

February 24, 1984

Tobacco Regulation: ACS Advocates Giving FDA Full Authority Over Tobacco

January 23, 1998

More Cost-Effective To Use Cetuximab In Patients With Wild-Type KRAS Gene

August 28, 2009

Counter-Point: George Sledge Responds To Berry’s Letter: Neoadjuvant Doesn’t Predict Adjuvant In Breast Cancer

July 11, 2014

FDA News: Consolidation Plan Designed For Savings

June 5, 1998

DeVita Will Ask NTP To Return Some NCI Funs To help Cover Shortfall In Center Core Budget

January 18, 1980